53
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Does early improvement in depressive symptoms predict subsequent remission in patients with depression who are treated with duloxetine?

, , &
Pages 1269-1273 | Published online: 23 May 2016

References

  • KatzMMTekellJLBowdenCLOnset and early behavioral effects of pharmacologically different antidepressants and placebo in depressionNeuropsychopharmacology20042956657914627997
  • StassenHHAngstJHellDIs there a common resilience mechanism underlying antidepressant drug response? Evidence from 2848 patientsJ Clin Psychiatry2007681195120517854243
  • SakuraiHUchidaHAbeTTrajectories of individual symptoms in remitters versus non-remitters with depressionJ Affect Disord201315150651323886402
  • NierenbergAAFarabaughAHAlpertJETiming of onset of antidepressant response with fluoxetine treatmentAm J Psychiatry20001571423142810964858
  • PapakostasGIPetersenTSklarskyKGTiming of clinical improvement and symptom resolution in the treatment of major depressive disorderPsychiatry Res200714919520017157390
  • MonteleoneFCaputoMTecceMFDuloxetine in the treatment of depression: an overviewCent Nerv Syst Agents Med Chem20111117418321919872
  • KatzMMMeyersALPrakashAEarly symptom change prediction of remission in depression treatmentPsychopharmacol Bull2009429410719204654
  • SenraCEvaluation and monitoring of symptom severity and change in depressed outpatientsJ Clin Psychol1996523173248835694
  • MulderRTJoycePRFramptonCRelationships among measures of treatment outcome in depressed patientsJ Affect Disord20037612713512943942
  • SuzukiAAoshimaTFukasawaTA three-factor model of the MADRS in major depressive disorderDepress Anxiety200521959715884092
  • KamataMSuzukiAYoshidaKGenetic polymorphisms in the serotonergic system and symptom clusters of major depressive disorderJ Affect Disord201113537437621917318
  • KornsteinSGWohlreichMMMallinckrodtCHDuloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trialsJ Clin Psychiatry20066776177016841626
  • CoppenAWhybrowPCNogueraRThe comparative antidepressant value of L-tryptophan and imipramine with and without attempted potentiation by liothyronineArch Gen Psychiatry1972262342414551048
  • KornsteinSGSchatzbergAFThaseMEGender differences in treatment response to sertraline versus imipramine in chronic depressionAm J Psychiatry20001571445145210964861
  • Old Age Depression Interest GroupHow long should the elderly take antidepressants? A double-blind placebo-controlled study of continuation/prophylaxis therapy with dothiepinBr J Psychiatry19931621751828435687
  • MorishitaSAritaSDifferential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in genderEur Psychiatry20031841842014680720
  • TomitaTYasui-FurukoriNSatoYSex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early responseNeuropsychiatr Dis Treat20141059960624748795
  • VermeidenMKampermanAMVulinkMEEarly improvement as a predictor of eventual antidepressant treatment response in severely depressed inpatientsPsychopharmacology (Berl)20152321347135625338776